Swarajya Logo

Politics

To Legalise Cannabis Or Not, That Is The Question -- And There’s No Answer Yet

  • A new scientific report on cannabis is honest about the benefits -- and harms -- of pot.
  • But the question of legalisation continues to be complex, and there’s no decisive argument on either side.

Theodore Dalrymple Feb 03, 2017, 03:45 PM | Updated 03:45 PM IST
An Indian sadhu  puffs cannabis (BIJU BORO/AFP/Getty Images)

An Indian sadhu puffs cannabis (BIJU BORO/AFP/Getty Images)


It’s curious how people’s beliefs about matters of fact often follow their political opinions, rather than the other way around. Those who believe in an active regulatory state are much more likely to believe in man-made global warming than those who want to reduce the role of the state to a minimum -- though whether such warming exists or not is, or ought to be, a matter of empirical fact. Strictly speaking, it would be possible to believe in man-made global warming without subscribing to the need for close regulation; but, in practice, political and empirical beliefs usually go together.

It is the same with cannabis. Those in favour of legalisation -- or liberalisation -- tend to emphasise its benefits and deny its harms; those against emphasise the harms and deny the benefits.

A report just published by the National Academies of Science, Engineering and Medicine tries dispassionately to assess the evidence for the health benefits and harms of cannabis and cannabinoids (the active chemicals in marijuana). It steers clear, quite rightly, of polemics: for, as Hume argued, no statement of value is to be derived from statements of fact. Where the evidence is not yet strong, or where there is none, the report says so.


Does any of this advance the argument for or against legalisation? I don’t think so. That cannabinoids should be treated as ordinary medications has always seemed to me reasonable. Of course, when given as medicine, the fun is rather taken out of them: there is no longer any thrill of the illicit. But if cannabinoids relieve unpleasant symptoms, it would be wrong to withhold them.

The question of legalisation -- or liberalisation -- is complex, and there is no decisive argument on either side. Is the pleasure of 100 men equal to the suffering of one additional psychotic or one extra road fatality (assuming that legalisation increases consumption and creates one additional psychotic or road fatality per 100 additional consumers)? I don’t see that there is a way of reducing the two sides of the equation to a common measure, and therefore reasonable people might disagree. Another question in our society seems to be, increasingly, whether they will agree to disagree civilly.

This piece was first published on City Journal, and has been republished here with permission.

Join our WhatsApp channel - no spam, only sharp analysis